ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997